These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 19856796

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Requirements for product quality of theophylline sustained-release preparations].
    Fuchs WS, Hens C, von Nieciecki A.
    Arzneimittelforschung; 1998 May; 48(5A):556-61. PubMed ID: 9676344
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Relative bioavailability and bioequivalence study of theophylline sustained release formulations.
    Vergin H, Mahr G, Winterhalter B, Wigand R.
    Arzneimittelforschung; 2003 May; 53(9):635-9. PubMed ID: 14558437
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Pharmacokinetics of a new fluid theophylline sustained-release drug form. Microcapsules in a sachet].
    Fuchs WS, Weiss G, von Nieciecki A, Laicher A, Gay S, Pabst G, Müller M.
    Arzneimittelforschung; 1998 May; 48(5A):612-7. PubMed ID: 9676354
    [Abstract] [Full Text] [Related]

  • 8. [Pharmacokinetics of a theophylline sustained-release formulation after single and twice daily dosage].
    Fuchs WS, von Nieciecki A, Pabst G, Müller M, Dilger C, Gay S, Laicher A, Stanislaus F.
    Arzneimittelforschung; 1998 May; 48(5A):589-92. PubMed ID: 9676350
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Reduction in health care resource utilization associated with extended-release theophylline.
    Schulz RM, Yates WN.
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):267-72. PubMed ID: 10094217
    [Abstract] [Full Text] [Related]

  • 11. [Slow-release theophylline for the treatment of asthmatic children].
    Iwasaki E, Baba M.
    Nihon Rinsho; 1996 Nov; 54(11):3102-7. PubMed ID: 8950962
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Theophylline controlled-release formulations: in vivo-in vitro correlations.
    Yu Z, Schwartz JB, Sugita ET.
    Biopharm Drug Dispos; 1996 Apr; 17(3):259-72. PubMed ID: 8983400
    [Abstract] [Full Text] [Related]

  • 15. [Health insurance discount contracts: problems and risks for the general practitioner in the medical care of patients with chronic illness].
    Leutgeb R, Mahler C, Laux G, Weschnetz A, Szecsenyi J.
    Dtsch Med Wochenschr; 2009 Jan; 134(5):181-6. PubMed ID: 19180404
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Frequency of hospitalizations prior to and after conversion to a rebate pharmaceutical in depression patients in Germany.
    Kostev K, May U, Ott C, Paul M, Schetschok K, Tingelhoff M, Claus C, Waehlert L.
    Int J Clin Pharmacol Ther; 2013 May; 51(5):416-22. PubMed ID: 23547855
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Chronopharmacokinetics of theophylline administered as a controlled-release tablet.
    Thielemann AM, Manquez N, Pinilla E, Gai MN, Romero P, Arancibia A, Chavez H.
    Int J Clin Pharmacol Ther; 1996 Mar; 34(3):130-3. PubMed ID: 8705090
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.